Stakeholder Communication

Stakeholder Identification and Engagement

Bora Pharmaceuticals values the interests of all stakeholders and is committed to open, transparent, and effective communication. We systematically identify key sustainability concerns by consulting internal teams, external experts, and referencing the GRI Standards published by the Global Reporting Initiative (GRI) and industry trends. The process includes departmental interviews and questionnaires to gather insights.

Stakeholder Identification	Issue Compilation and Questionnaire Survey	Major Issue Analysis and Ranking	Issue Disclosure and Discussion
Through internal discussions, 6 main stakeholder groups were identified: employees, investors, customers, and suppliers.	Based on GRI Standards as the foundation for issue collection, sustainability issues were identified according to their relevance and Bora’s industry characteristics for the questionnaire design. Last year’s major issues were used as a baseline, and Bora’s management team assessed the importance and stakeholder concern of the issues.	After calculating and analyzing the major issues for 2024, we assessed their importance based on their scores and categorized them into high, medium, and general issues.	We responded to the major issues in the corresponding sections of this year’s report and will continue to strengthen management of these issues in the future.

Stakeholder Identification

Through discussions among department heads, Bora identified 6 main stakeholder groups: employees, investors, customers, and suppliers.

Communication with each group is tailored to address their specific concerns. By implementing sustainability strategy projects and conducting relevance reviews, we evaluate stakeholder alignment and communication effectiveness, continuously improving our response to the needs of different stakeholders. Bora ensures that stakeholder needs are addressed by regularly reviewing and refining our communication practices. Annual stakeholder communication reports are regularly presented to the Board of Directors. The latest communication status was reported to the Board on November 13, 2024.

Stakeholder	Communication Channels, Response Methods and Frequency	2024 Engagement Highlights
Employees	Department communication and mission-group meetings (daily) Site level meetings (weekly) Internal e-newsletter (monthly) Employee general meetings (quarterly) Labor management meetings (quarterly) Occupational Safety and Health Committee meetings(quarterly) Performance appraisal interviews (annually) Occupational safety and health education and training (annually) Employee Welfare Committee meetings (quarterly) Compensation Committee meetings (at least twice a year) Employee training programs (time to time) Employee suggestion box and complaint mailbox (real-time) Internal website (time to time)	A total of 5 mid-to-senior level management leadership courses (High-Performance Teams, Accountability, Systems Thinking and Decision Making, Thunderbird, Project Management) were completed across Bora network in Taiwan, with 223 total participants and 2,317.5 training hours. Four employee town halls were held across Bora network in Taiwan (on May 22, September 2, September 30, and December 24), where the Chairman delivered key messages related to operations and future of the Company and conducted Q&A sessions. Overseas sites achieved the goal of holding quarterly town halls for better internal communication. Four labor-management meetings were held at headquarter (on March 20, June 14, September 27, and December 20). 100 percent participation in annual appraisals evaluation reached 100 percent. Bora Family Day (September 21) welcomed a total of 1,502 participants, including employees and their families. On July 5, Bora received the 2024 HR Asia Best Companies to Work for in Asia Award and the Best Employer for Commitment to Employee Welfare Award. On October 17, the third-party grievance and whistleblower platform“Conduct Watch” went live.
Investors	Annual General Shareholders’ Meeting (annually) Corporate Investor Conferences (semiannually) Investor Forums (time to time) Financial Report (quarterly) Revenue Performance Disclosure (monthly) Disclosure of material financial and business information on the Market Observation Post System (time to time) Designated spokesperson, deputy spokesperson and media contact (real-time) Dedicated investor relations email and contact window (real-time)	Held 1 general shareholders’ meeting. Held 9 corporate investor conferences. Held 91 investor meetings. Disclosed 136 material announcements in both Chinese and English on the Market Observation Post System.
Customers	Customer audits Corporate website Customer service email (real-time) Business information provided through website and social media platforms (time to time) E-newsletters (time to time) Face to face events: seminars, patient support groups, industry conferences and product briefings to facilitate communication (time to time)	Received inquiries from at least 28 customers via the Bora website, all responded to within one business day. A total of 6 product complaints have been received in 2024, all resolved with no adverse impact. In 2024, more than 30 product briefings, 16 seminars, 18 patient support group events, 5 medical conferences, and 7 exhibitions have been held at pharmacies, clinics, and hospitals. Corporate website regularly maintained with product and business-related updates.
Suppliers	Supplier management is conducted according to SOP with raw materials and excipients purchased from vendors listed in the approved and verified supplier list In accordance with PIC/S regulations, periodic audits of suppliers involved in GMP-related activities are conducted based on historical audit results and risk assessments	In 2024, we completed the evaluation of non-material suppliers and issued a comprehensive report. Each supplier was assessed based on business continuity and management performance, serving as a basis for future cooperation decisions. In the same year, audits of all GMP-related suppliers were also completed.Held meetings with relevant departments to discuss the guidelines and practices for establishing a supplier code of conduct. Incorporated the above principles and practices into purchase order terms, new supplier information forms and SOPs, while corresponding revisions and implementation currently in progress.
Communities	Community service activities (at least once per site annually) Public welfare events (at least one per market annually) Corporate website (real-time) Social media platforms (real-time)	Donated NT$200,000 to the Taiwan Parkinson’s Disease Association, benefiting 100 Parkinson’s patients. Invited 150 faculty and students from four universities to visit the manufacturing sites for industry-academia exchange. Sponsored the Red Nose Clown Care Association with a contribution of NT$170,000, serving 59 children with a total of 173 service engagements. Supported neighboring schools by helping 240 underprivileged children fulfill their Christmas wishes. Donated NT$900,000 to the Mennonite Christian Hospital Foundation in Taiwan to support post-earthquake reconstruction efforts. Collaborated with the Teacher Chang Foundation to host a “Grief Counseling Practice Series” seminar, attracting 60 participants. Partnered with Hsuan Liu’s podcast to launch juvenile mental health content, reaching a total of 136,000 listeners. Upsher-Smith continues to sponsor the Tuberous Sclerosis Alliance in the US and is recognized as a Tier 2 sponsor.
Government	Regulatory compliance meetings (as needed) Policy briefings (as needed) Official correspondence (as needed) Government inspections and audits (as scheduled by authorities) Market Observation Post System (real-time)	Participated in meetings organized by relevant authorities to understand policy changes and to be able to promptly respond to regulatory changes if any. Responded formally to government inquiries and requests through official correspondence channels to ensure information accuracy and completeness. Cooperated with government inspections and audits by providing required documentation and implementing necessary corrective actions afterward. Disclosed material company information in a timely manner on the Market Observation Post System to ensure transparency.

To effectively gather stakeholder opinions and expectations, Bora outlines clear communication channels and frequencies for each stakeholder group. We maintain transparent, diverse channels, including an external communication mailbox accessible via our official website.

Communication Channels

Investor Contact Information

Spokesperson: Ms. Alice Wang

Deputy Spokesperson: Ms. Nadiya Chen

Media Contact: Ms. Nadiya Chen

Phone: +886-2-2790-1555

Email: public01@bora-corp.com

Stock Affairs Agent

Name: Taishin Securities Co., Ltd.

Website: https://www.taishinbank.com.tw

Address: B1, No. 96, Section 1, Jianguo North Road, Zhongshan District, Taipei City 10489

Phone: (02) 2504-8125

Customer Contact

Bora Pharmaceuticals provides professional CDMO services with advanced facilities adhering to international standards, offering customized services.

Customer Contact: Ms. Wang

Email: weni.wang@bora-corp.com

Supplier Contact

Bora Pharmaceuticals uses strict standards to select suppliers, maintaining long-term and stable cooperation, conducting regular audits and safety meetings.

Supplier Contact: Ms. Chung

Email: ruby.chung@bora-corp.com

Employee Relations and Welfare

Bora Pharmaceuticals values employee rights, regularly holds Welfare Committee meetings, conducts informal communication meetings, follows UN Guiding Principles on Business and Human Rights, and adheres to international labor safety and health protection measures, creating a friendly workplace environment.

Employee Contact: Ms. Ellen Chen

Email: hr80@bora-corp.com

Environmental Safety and Health

Bora Pharmaceuticals aims for sustainable operations, focusing on occupational safety, environmental protection, and pollution prevention.

Environmental Safety and Health Contact: Mr. Chang

Email: miller.chang@bora-corp.com

Anti-Corruption Reporting Mailbox

Bora Pharmaceuticals has established “Integrity Management Code,” “Code of Ethical Conduct,” “Employee Reward and Punishment Regulations,” and various personnel management methods, with rigorous reporting mechanisms to ensure employees can report concerns confidentially and safely. In 2023, one whistleblowing incident was reported through the dedicated mailbox. After the internal investigation was conducted, no conclusive evidence was found. However, appropriate measures were taken to strengthen management. Additionally, no other complaints regarding dishonesty, unethical behavior, or suspected insider trading violations were received.

Anti-Corruption Reporting Contact: Ms. Ellen Chen

Email: hr80@bora-corp.com

Stakeholder Identification and Engagement

Stakeholder Identification

Communication Channels

Bora

Contact

Address

Quick Links